CIK 0001348362
- Non-accelerated filer
- Smaller reporting company
Lexaria Bioscience Corp.
Sign in to watch- Ticker
- LEXX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Aug 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 202000871
- Phone
- +1 250-765-6424
- Business address
- 100 - 740 MCCURDY ROAD, KELOWNA, British Columbia, Canada, V1X 2P7
- Former names
- Lexaria Corp., LEXARIA CORP.
- 4 Grant or award CEO acquired 81,250 shares (grant or award)
- 4 Grant or award Director acquired 273,750 shares (grant or award)
- 4 Exercise or conversion CEO acquired 697,500 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 50,000 shares at an average $1.90 ($95,001)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award CFO acquired 41,666 shares (grant or award)
- 4 Grant or award Director acquired 14,634 shares (grant or award)
- 4 Grant or award Director acquired 35,000 shares (grant or award)
- 4 Grant or award CEO acquired 29,475 shares (grant or award)
- 4 Grant or award Director acquired 32,433 shares (grant or award)
- 4 Grant or award CEO acquired 210,000 shares (grant or award)
- 4/A Grant or award Director acquired 35,294 shares (grant or award)
- 4 Grant or award President acquired 210,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 35,249 shares (grant or award)
- 4 Grant or award Director acquired 29,091 shares (grant or award)
- 4 Derivatives Options or other derivatives
Page 7 of 21 · 420 filings